Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-Florastamin PET/CT in Suspected Recurrence of Prostate Cancer
NCT06754085Phase 3Completed
- Start
- Dec 2024
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 18f-florastamin in prostate cancer (PCa). Started Dec 2024; status: completed.
02
Drugs
18f-florastamin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06754085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06754085.